Quick Answer
IN8BIO, INC. reported Stockholders Equity of $27.56 million for fiscal year 2025.
IN8BIO, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $27.56M | +90.3% |
| 2024 | $14.48M | -41.9% |
| 2023 | $24.94M | +9.7% |
| 2022 | $22.73M | +159.5% |
| 2021 | -$38.18M | -130.3% |
| 2020 | -$16.58M | -79.4% |
| 2019 | -$9.24M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.19M | +53.6% | -13.5% |
| June 30, 2025 | $15.24M | +11.9% | +9.8% |
| March 31, 2025 | $13.88M | -20.8% | -4.2% |
| December 31, 2024 | $14.48M | -41.9% | +68.6% |
| September 30, 2024 | $8.59M | -51.6% | -37.0% |
| June 30, 2024 | $13.62M | -37.5% | -22.3% |
| March 31, 2024 | $17.53M | +4.4% | -29.7% |
| December 31, 2023 | $24.94M | +9.7% | +40.4% |
- IN8BIO, INC. showed an increase of +90.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, IN8BIO, INC.’s stockholders equity has grown by 398.2% (from -$9.24 million to $27.56 million).
- The most recent figure is from IN8BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: